Kumudu Pathiraja
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Immunology top 2%
- Surgery top 5%
- Cancer Research top 5%
- Co-authors
- Shilpa GuptaRavit GevaJonathan D. ChengRaanan BergerLaura Q.M. ChowVassiliki KarantzaLaurence BuisseretLajos Pusztai
- Topics
- Cancer Immunotherapy and Biomarkers (23 papers)CAR-T cell therapy research (10 papers)Lymphoma Diagnosis and Treatment (10 papers)
- Partner nations
- United StatesIsraelSouth Korea
In The Last Decade
Kumudu Pathiraja
34 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 2.7k
- Pulmonary and Respiratory Medicine 1.2k
- Immunology 1.0k
- Surgery 575
- Cancer Research 490
Countries citing papers authored by Kumudu Pathiraja
This map shows the geographic impact of Kumudu Pathiraja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumudu Pathiraja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumudu Pathiraja more than expected).
Fields of papers citing papers by Kumudu Pathiraja
This network shows the impact of papers produced by Kumudu Pathiraja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumudu Pathiraja. The network helps show where Kumudu Pathiraja may publish in the future.
Co-authorship network of co-authors of Kumudu Pathiraja
This figure shows the co-authorship network connecting the top 25 collaborators of Kumudu Pathiraja. A scholar is included among the top collaborators of Kumudu Pathiraja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumudu Pathiraja. Kumudu Pathiraja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 208 | |
| 8 | 12 | |
| 9 | Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012breakdown → | 329 |
| 10 | 16 | |
| 11 | Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trialbreakdown → | 848 |
| 12 | 5 | |
| 13 | 6 | |
| 14 | 10 | |
| 15 | 74 | |
| 16 | 24 | |
| 17 | 90 | |
| 18 | 41 | |
| 19 | 19 | |
| 20 | 39 |
About Kumudu Pathiraja
Kumudu Pathiraja is a scholar working on Oncology, Gastroenterology and Pathology and Forensic Medicine, having authored 36 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (23 papers), CAR-T cell therapy research (10 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Oncology (2.7k citations), Immunology (1.0k citations) and Otorhinolaryngology (166 citations). Kumudu Pathiraja has collaborated with scholars based in United States, Israel and South Korea. Frequent co-authors include Shilpa Gupta, Ravit Geva, Jonathan D. Cheng, Raanan Berger, Laura Q.M. Chow, Vassiliki Karantza, Laurence Buisseret, Lajos Pusztai, Rita Nanda and Gursel Aktan. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.